Haider Warraich
speaker
683 appearances
3 recordings
1 series
first heard Oct 2020
last heard Dec 2021
Haider Warraich’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
Because everybody's different, right?
Some people get it in their ankles.
Some people get it in their thighs.
Some people in their back.
Some people in their bellies.
And some people just have initially present with more sort of pulmonary edema, pleural effusions.
And if a patient says, it often will sway me in that direction, especially in people who've lived with it for a long time.
They know this.
They've got this down.
This
Yeah, totally, totally different.
And just to explain to folks, you know, the one really good thing nowadays is that VAD therapy has improved quite a bit.
So if essentially in the United States, the only VAD that we are implanting or should be being, we should be implanting in the long-term setting is the HeartMate 3L VAD.
And the biggest difference between the HeartMate 3L VAD over previous LVADs is that it has an almost negligible rate of VAD thrombosis.
So clots forming in
the VAD.
And this is a huge advance because it has a lot of downstream effects.
So if you have fewer clot forming in the VAD, you'll have fewer strokes.
If you're less worried about VAD thrombosis, then you're less militant about how aggressively you anticoagulate these patients.
But I think in some ways a VAD is sort of like the same way I pitch transplant to patients, where I feel like this will make your heart failure better, but in some ways you are exchanging one set of problems for another.
Showing 221–240 of 683 · page 12 of 35
← Previous
Next →